Quick Answer
CANNAPHARMARX, INC. reported Stockholders Equity of -$30.15 million for the year ending 2025.
- CANNAPHARMARX, INC. showed a decrease of -52.2% in Stockholders Equity from 2024 to 2025.
- This data is from CANNAPHARMARX, INC.'s annual report (Form 10-K), filed with the SEC on March 31, 2026.
- XBRL data for this metric is available from 2009 to 2025 (17 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q2 2013: -$244.6 thousand | Q3 2013: -$269.8 thousand | Q1 2014: -$317.7 thousand | Q2 2014: $1.98 million | Q3 2014: $2.45 million | Q1 2015: -$551.6 thousand | Q2 2015: $406.0 thousand | Q3 2015: -$204.8 thousand | Q1 2016: -$828.5 thousand | Q2 2016: -$891.9 thousand | Q3 2016: -$921.4 thousand | Q1 2017: -$959.3 thousand | Q2 2017: -$959.3 thousand | Q3 2017: -$959.3 thousand | Q1 2018: -$964.3 thousand | Q2 2018: -$974.8 thousand | Q3 2018: -$1.16 million | Q1 2019: $12.28 million | Q2 2019: $11.73 million | Q3 2019: $12.61 million | Q1 2020: $1.35 million | Q2 2020: $2.73 million | Q3 2020: $1.46 million | Q1 2021: -$6.85 million | Q2 2021: -$6.39 million | Q3 2021: -$6.29 million | Q1 2022: -$14.29 million | Q2 2022: -$14.70 million | Q3 2022: -$14.98 million | Q1 2023: -$18.21 million | Q2 2023: -$20.14 million | Q3 2023: -$20.63 million | Q1 2024: -$23.53 million | Q2 2024: -$16.67 million | Q3 2024: -$16.58 million | Q1 2025: -$20.51 million | Q2 2025: -$22.57 million | Q3 2025: -$22.52 million.
- Over the full 17 years of available data (2009 to 2025), CANNAPHARMARX, INC.'s Stockholders Equity has declined by 5,132.3%.
- Historical annual values: Fiscal year 2025: -$30.15 million | Fiscal year 2024: -$19.81 million | Fiscal year 2023: -$12.15 million | Fiscal year 2022: $17.34 million | Fiscal year 2021: -$12.93 million | Fiscal year 2020: -$8.80 million | Fiscal year 2019: $4.85 million | Fiscal year 2018: -$286.3 thousand | Fiscal year 2017: -$964.3 thousand | Fiscal year 2016: -$957.7 thousand | Fiscal year 2015: -$684.5 thousand | Fiscal year 2014: -$288.2 thousand | Fiscal year 2013: -$292.0 thousand | Fiscal year 2012: -$197.6 thousand | Fiscal year 2011: -$99.6 thousand | Fiscal year 2010: $100.00 | Fiscal year 2009: -$576.3 thousand.
- Data sourced from SEC EDGAR public filings as of August 5, 2026.
Last verified: